Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9BHB

Cryo-EM structure of human monoclonal antibody C74 targeting PFD1235w (CIDRa1.6) PfEMP1

Summary for 9BHB
Entry DOI10.2210/pdb9bhb/pdb
EMDB information44539
DescriptorC74 heavy chain, C74 kappa chain, Erythrocyte membrane protein 1, PfEMP1 (3 entities in total)
Functional Keywordsantibody, plasmodium, monoclonal, neutralizing, immune system
Biological sourceHomo sapiens
More
Total number of polymer chains3
Total formula weight110688.77
Authors
Raghavan, S.S.R.,Ward, A.B. (deposition date: 2024-04-19, release date: 2024-10-02, Last modification date: 2025-06-04)
Primary citationReyes, R.A.,Raghavan, S.S.R.,Hurlburt, N.K.,Introini, V.,Bol, S.,Kana, I.H.,Jensen, R.W.,Martinez-Scholze, E.,Gestal-Mato, M.,Lopez-Gutierrez, B.,Sanz, S.,Bancells, C.,Fernandez-Quintero, M.L.,Loeffler, J.R.,Ferguson, J.A.,Lee, W.H.,Martin, G.M.,Theander, T.G.,Lusingu, J.P.A.,Minja, D.T.R.,Ssewanyana, I.,Feeney, M.E.,Greenhouse, B.,Ward, A.B.,Bernabeu, M.,Pancera, M.,Turner, L.,Bunnik, E.M.,Lavstsen, T.
Broadly inhibitory antibodies to severe malaria virulence proteins.
Nature, 636:182-189, 2024
Cited by
PubMed Abstract: Malaria pathology is driven by the accumulation of Plasmodium falciparum-infected erythrocytes in microvessels. This process is mediated by the polymorphic erythrocyte membrane protein 1 (PfEMP1) adhesion proteins of the parasite. A subset of PfEMP1 variants that bind to human endothelial protein C receptor (EPCR) through their CIDRα1 domains is responsible for severe malaria pathogenesis. A longstanding question is whether individual antibodies can recognize the large repertoire of circulating PfEMP1 variants. Here we describe two broadly reactive and inhibitory human monoclonal antibodies to CIDRα1. The antibodies isolated from two different individuals exhibited similar and consistent EPCR-binding inhibition of diverse CIDRα1 domains, representing five of the six subclasses of CIDRα1. Both antibodies inhibited EPCR binding of both recombinant full-length and native PfEMP1 proteins, as well as parasite sequestration in bioengineered 3D human brain microvessels under physiologically relevant flow conditions. Structural analyses of the two antibodies in complex with three different CIDRα1 antigen variants reveal similar binding mechanisms that depend on interactions with three highly conserved amino acid residues of the EPCR-binding site in CIDRα1. These broadly reactive antibodies are likely to represent a common mechanism of acquired immunity to severe malaria and offer novel insights for the design of a vaccine or treatment targeting severe malaria.
PubMed: 39567685
DOI: 10.1038/s41586-024-08220-3
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (3.1 Å)
Structure validation

247035

PDB entries from 2026-01-07

PDB statisticsPDBj update infoContact PDBjnumon